Happy Media

Hindustan Times Dated: April 27, 2020 Vaccine major Serum Institute of India on Sunday said it plans to start production of the Covid-19 vaccine developed by Oxford University in the next two to three weeks and hopes to bring it to the market by October if the human clinical trials are successful.The Pune-based company has partnered with Oxford University as one of the seven global institutions manufacturing the vaccine. “Our team has been working closely with Dr Hill from Oxford University, and we are expecting to initiate production of the vaccine in 2-3 weeks and produce 5 million doses per month for the first 6 months, following which, we hope to scale up production to 10 million doses per month,” Serum Institute India (SII) CEO Adar Poonawalla said. SII has collaborated with scientists at Oxford University for a malaria vaccine project in the past and can say with certainty that they are some of the best scientists, he added. “We expect the (COVID-19) vaccine to be out

Outlook Dated April 26, 2020 The CBDT on Sunday said an inquiry is being initiated against 50 IRS officers of the I-T department who have penned an unsolicited report on revenue mobilisation to fund COVID-19 relief measures and made it public without permission. In a statement, the Central Board of Direct Taxes (CBDT), which is the apex policy-making body for direct tax policies, said it has never asked IRS Association or these officers to prepare such a report and no permission was sought by them before making the report public. "It is unequivocally stated that CBDT never asked IRS Association or these officers to prepare such a report. "No permission was sought by the officers before going public with their personal views and suggestions on official matters, which is a violation of extant Conduct Rules. A necessary inquiry is being initiated in this matter," the CBDT said. It further said the "impugned report" does not reflect the official vie